New York Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 713,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "eb9c9ccb-5e83-429f-a274-3dc3a4318fc5",
"title": "3D Imaging Market worth $88.4 billion by 2028, growing at a CAGR of 20.8%: Report by MarketsandMarkets™",
"description": "Chicago, March 29, 2024 (GLOBE NEWSWIRE) -- The global 3D Imaging Market is projected to grow from USD 34.3 billion in 2023 to USD 88.4 billion by 2028,...",
"keywords": "MarketsandMarkets Research Pvt. Ltd., 3D Imaging Market, 3D Imaging Market Size, 3D Imaging Market Share, Global 3D Imaging Market, 3D Imaging, 3D Imaging Industry",
"snippet": "Chicago, March 29, 2024 (GLOBE NEWSWIRE) -- The global 3D Imaging Market is projected to grow from USD 34.3 billion in 2023 to USD 88.4 billion by 2028, at a CA...",
"url": "https://www.globenewswire.com/news-release/2024/03/29/2854744/0/en/3D-Imaging-Market-worth-88-4-billion-by-2028-growing-at-a-CAGR-of-20-8-Report-by-MarketsandMarkets.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/afcc5182-4ae0-43a8-a965-4351d590b7ed",
"language": "en",
"published_at": "2024-03-29T14:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "SONY",
"name": "Sony Group Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 9.191927,
"sentiment_score": 0.5423,
"highlights": [
{
"highlight": "solutions and hardware\n\nOpportunities:\n\nAdoption of 3D printing in healthcare\n\nIncreasing investments in AI by 3D medical imaging device manufacturers\n\nHigh demand for 3D imaging solutions in retail & eCommerce vertical\n\nList of Key Players in 3D Imaging Market:\n\nGE Healthcare (US)\n\nAutodesk (US)\n\nSTMicroelectronics (Switzerland)\n\nPanasonic (Japan)\n\n<em>Sony</em>",
"sentiment": 0.5423,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "c3e5d82b-bba4-43d3-bd27-9dfd498b6e6f",
"title": "Pharmaceutical Membrane Filtration Market is Expected to Reach $19.6 billion | MarketsandMarkets™",
"description": "Chicago, March 29, 2024 (GLOBE NEWSWIRE) -- Pharmaceutical Membrane Filtration market in terms of revenue was estimated to be worth $10.6 billion in 2024...",
"keywords": "MarketsandMarkets Research Pvt. Ltd., Pharmaceutical Membrane Filter, Pharmaceutical Membrane, Pharmaceutical Filtration Mrkt, Membrane Filtration Market",
"snippet": "Chicago, March 29, 2024 (GLOBE NEWSWIRE) -- Pharmaceutical Membrane Filtration market in terms of revenue was estimated to be worth $10.6 billion in 2024 and is...",
"url": "https://www.globenewswire.com/news-release/2024/03/29/2854723/0/en/Pharmaceutical-Membrane-Filtration-Market-is-Expected-to-Reach-19-6-billion-MarketsandMarkets.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/afcc5182-4ae0-43a8-a965-4351d590b7ed",
"language": "en",
"published_at": "2024-03-29T12:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "MMM.SW",
"name": "3M Company",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Industrials",
"match_score": 10.747011,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n<em>3M</em> <em>Company</em> (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "G1LW34.SA",
"name": "Corning Incorporated",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 17.06239,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\n<em>Corning</em> <em>Incorporated</em> (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MMMC34.SA",
"name": "3M Company",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Industrials",
"match_score": 10.746974,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n<em>3M</em> <em>Company</em> (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHER34.SA",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.512548,
"sentiment_score": 0,
"highlights": [
{
"highlight": "id=255408031\n\nPharmaceutical Membrane Filtration market major players covered in the report, such as:\n\nMerck KGaA (Germany)\n\n<em>Danaher</em> <em>Corporation</em> (US)\n\nSartorius AG (Germany)\n\nThermo Fisher Scientific, Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "E1TN34.SA",
"name": "Eaton Corporation plc",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Industrials",
"match_score": 18.249453,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\n<em>Eaton</em> <em>Corporation</em> <em>plc</em> (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "RGEN",
"name": "Repligen Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 16.018578,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\n<em>Repligen</em> <em>Corporation</em> (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MMM",
"name": "3M Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 10.746929,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n<em>3M</em> <em>Company</em> (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GLW",
"name": "Corning Incorporated",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 17.061325,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\n<em>Corning</em> <em>Incorporated</em> (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHR",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.512147,
"sentiment_score": 0,
"highlights": [
{
"highlight": "id=255408031\n\nPharmaceutical Membrane Filtration market major players covered in the report, such as:\n\nMerck KGaA (Germany)\n\n<em>Danaher</em> <em>Corporation</em> (US)\n\nSartorius AG (Germany)\n\nThermo Fisher Scientific, Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ETN",
"name": "Eaton Corporation plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 18.2497,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\n<em>Eaton</em> <em>Corporation</em> <em>plc</em> (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PH",
"name": "Parker-Hannifin Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 22.152853,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\n<em>Parker</em> <em>Hannifin</em> <em>Corporation</em> (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CMD",
"name": "Cantel Medical Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 21.65407,
"sentiment_score": 0.6166,
"highlights": [
{
"highlight": "(US)\n\nCole-Parmer Instrument Company, LLC (US)\n\nApplexion (France)\n\n<em>Cantel</em> <em>Medical</em> <em>Corp</em>. (US)\n\nW. L. Gore & Associates Inc. (US)\n\nMembrane Solutions (US)\n\nAmazon Filters Ltd. (UK)\n\nToyo Roshi Kaisha, Ltd. (Japan)\n\nPorvair plc (UK)\n\nSterlitech Corporation (US)\n\nSynder Filtration, Inc. (US)\n\nGraver Technologies, LLC (US)\n\nKoch Membrane Systems, Inc.",
"sentiment": 0.6166,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DCI",
"name": "Donaldson Company, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 14.049631,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\n<em>Donaldson</em> <em>Company</em>, <em>Inc</em>. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TMO",
"name": "Thermo Fisher Scientific Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 26.29615,
"sentiment_score": 0,
"highlights": [
{
"highlight": "id=255408031\n\nPharmaceutical Membrane Filtration market major players covered in the report, such as:\n\nMerck KGaA (Germany)\n\nDanaher Corporation (US)\n\nSartorius AG (Germany)\n\n<em>Thermo</em> <em>Fisher</em> <em>Scientific</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AHKSY",
"name": "Asahi Kasei Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 25.1314,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\n<em>Asahi</em> <em>Kasei</em> <em>Corporation</em> (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AHKSF",
"name": "Asahi Kasei Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 25.1314,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\n<em>Asahi</em> <em>Kasei</em> <em>Corporation</em> (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MMMD.BA",
"name": "3M COMPANY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 10.746757,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n<em>3M</em> <em>Company</em> (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GLW.BA",
"name": "Corning Incorporated",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 17.060574,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\n<em>Corning</em> <em>Incorporated</em> (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MMM.SN",
"name": "3M Company",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Industrials",
"match_score": 10.746746,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n<em>3M</em> <em>Company</em> (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MMMCL.SN",
"name": "3M Company",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 10.746746,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n<em>3M</em> <em>Company</em> (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\nAsahi Kasei Corporation (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "3407.T",
"name": "Asahi Kasei Corporation",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Basic Materials",
"match_score": 25.12777,
"sentiment_score": 0,
"highlights": [
{
"highlight": "(US)\n\n3M Company (US)\n\nParker Hannifin Corporation (US)\n\nRepligen Corporation (US)\n\n<em>Asahi</em> <em>Kasei</em> <em>Corporation</em> (Japan)\n\nEaton Corporation plc (Ireland)\n\nGEA Group (Germany)\n\nCorning Incorporated (US)\n\nAlfa Laval Corporate AB (Sweden)\n\nDonaldson Company, Inc. (US)\n\nSaint-Gobain (France)\n\nMANN+HUMMEL International GmbH & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "443ef7ef-8eb6-43ab-9d5a-0d5b4e52d6f1",
"title": "Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%",
"description": "The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is Expected to Reach USD 2.18 Billion by...",
"keywords": "SPHERICAL INSIGHTS LLP, Pregabalin Market, Pregabalin Market Size, Pregabalin Market Share, Pregabalin Market Growth, Pregabalin Market Analysis, Trends, Si",
"snippet": "New York, United States , March 29, 2024 (GLOBE NEWSWIRE) -- The Global Pregabalin Market Size is to Grow from USD 1.65 Billion in 2023 to USD 2.18 Billion by 2...",
"url": "https://www.globenewswire.com/news-release/2024/03/29/2854706/0/en/Global-Pregabalin-Market-Size-To-Worth-USD-2-18-Billion-By-2033-CAGR-of-2-82.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
"language": "en",
"published_at": "2024-03-29T11:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "VIA.DE",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.635052,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "Major vendors in the global pregabalin market include Cipla, Rising Pharmaceuticals, Angels Pharma, Zydus Group, <em>Viatris</em> <em>Inc</em>., Amneal Pharmaceuticals LLC., Aurobindo Pharma, Markans Pharma Ltd., Lupin Pharmaceuticals, Glenmark Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Sciegen Pharmaceuticals Inc., Novartis AG, Torrent Pharmaceuticals",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Get Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm <em>Viatris</em> <em>Inc</em>. The portfolio includes many anti-depressants, including pregabalin, anti-hypertensive, and ophthalmology products.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VTRS.MX",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 20.634972,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "Major vendors in the global pregabalin market include Cipla, Rising Pharmaceuticals, Angels Pharma, Zydus Group, <em>Viatris</em> <em>Inc</em>., Amneal Pharmaceuticals LLC., Aurobindo Pharma, Markans Pharma Ltd., Lupin Pharmaceuticals, Glenmark Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Sciegen Pharmaceuticals Inc., Novartis AG, Torrent Pharmaceuticals",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Get Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm <em>Viatris</em> <em>Inc</em>. The portfolio includes many anti-depressants, including pregabalin, anti-hypertensive, and ophthalmology products.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSN.MX",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.217969,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VTRSV",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 20.634033,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "Major vendors in the global pregabalin market include Cipla, Rising Pharmaceuticals, Angels Pharma, Zydus Group, <em>Viatris</em> <em>Inc</em>., Amneal Pharmaceuticals LLC., Aurobindo Pharma, Markans Pharma Ltd., Lupin Pharmaceuticals, Glenmark Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Sciegen Pharmaceuticals Inc., Novartis AG, Torrent Pharmaceuticals",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Get Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm <em>Viatris</em> <em>Inc</em>. The portfolio includes many anti-depressants, including pregabalin, anti-hypertensive, and ophthalmology products.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VTRS",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.634066,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "Major vendors in the global pregabalin market include Cipla, Rising Pharmaceuticals, Angels Pharma, Zydus Group, <em>Viatris</em> <em>Inc</em>., Amneal Pharmaceuticals LLC., Aurobindo Pharma, Markans Pharma Ltd., Lupin Pharmaceuticals, Glenmark Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Sciegen Pharmaceuticals Inc., Novartis AG, Torrent Pharmaceuticals",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Get Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm <em>Viatris</em> <em>Inc</em>. The portfolio includes many anti-depressants, including pregabalin, anti-hypertensive, and ophthalmology products.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVS",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.217814,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSEF",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.218015,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0K9E.L",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 12.218066,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NOVN.SW",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.21724,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "N1VS34.SA",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.217208,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GLENMARK.NS",
"name": "Glenmark Pharmaceuticals Limited",
"exchange": null,
"exchange_long": null,
"country": "in",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.325304,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., Lupin Pharmaceuticals, <em>Glenmark</em> <em>Pharmaceuticals</em> <em>Limited</em>, Teva Pharmaceutical Industries Ltd., Sciegen Pharmaceuticals Inc., Novartis AG, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSD.BA",
"name": "NOVARTIS AG",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 12.217447,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Torrent Pharmaceuticals Ltd., CTX Life Sciences, Others.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3884\n\nRecent Market Developments\n\nIn April 2023, Pakistani pharmaceutical firm AGP Limited acquired a selected portfolio of products from American firm Viatris Inc.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "3550dcc0-0faa-41e8-b9ab-b82784495442",
"title": "Danimer Scientific reports Q4 results (NYSE:DNMR)",
"description": "Danimer Scientific (DNMR) reports a Q4 preliminary adjusted EBITDA of $(10.7) million and a revenue of $10.9M, beating expectations.",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/news/4085316-danimer-scientific-reports-q4-results",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-03-29T13:33:24.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "DNMR",
"name": "Danimer Scientific, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 133.02469,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Danimer</em> <em>Scientific</em> reports Q4 results (<em>NYSE:DNMR</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "d1a4aa55-3bfa-4acb-b0f8-2a242747ffcd",
"title": "‘Helldivers 2’ Players Are About To Quite Literally Erase Automatons From The Map",
"description": "Helldivers 2 players are about to find that out on the frontier of the Automaton side of the galactic war.",
"keywords": "Helldivers 2, Automaton",
"snippet": "Helldivers Sony\n\nWhat happens when there is no more democracy left to spread? Helldivers 2 players are about to find that out on the frontier of the Automaton s...",
"url": "https://www.forbes.com/sites/paultassi/2024/03/29/helldivers-2-players-are-about-to-quite-literally-erase-automatons-from-the-map/",
"image_url": "https://imageio.forbes.com/specials-images/imageserve/65c6306ced2eb9dd7393e813/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
"language": "en",
"published_at": "2024-03-29T13:30:10.000000Z",
"source": "forbes.com",
"relevance_score": null,
"entities": [
{
"symbol": "SONY",
"name": "Sony Group Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 12.135903,
"sentiment_score": -0.8658,
"highlights": [
{
"highlight": "Helldivers <em>Sony</em>\n\nWhat happens when there is no more democracy left to spread? Helldivers 2 players are about to find that out on the frontier of the Automaton side of the galactic war. After crushing a sector in the last major order, now players are asked to take the lone remaining Automaton sector in the next three days.",
"sentiment": -0.8658,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "0dcb8c87-2b16-4422-8888-d201bf670e71",
"title": "Ford Motor Company Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting By Investing.com",
"description": "Ford Motor Company Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting",
"keywords": "",
"snippet": "DEARBORN, Mich.--(BUSINESS WIRE)--Ford today published its 2024 proxy statement and announced the date of the company's 2024 annual meeting of shareholders, whi...",
"url": "https://www.investing.com/news/press-releases/ford-motor-company-issues-2024-proxy-statement-announces-may-9-as-date-for-virtual-annual-meeting-93CH-3358041",
"image_url": "https://i-invdn-com.investing.com/news/LYNXMPEB310N9_L.jpg",
"language": "en",
"published_at": "2024-03-29T13:16:07.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "F",
"name": "Ford Motor Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 113.291855,
"sentiment_score": 0.3215,
"highlights": [
{
"highlight": "About <em>Ford</em> <em>Motor</em> <em>Company</em> (NYSE: )\n\n<em>Ford</em> <em>Motor</em> <em>Company</em> (<em>NYSE</em>: <em>F</em>) is a global company based in Dearborn, Michigan, committed to helping build a better world, where every person is free to move and pursue their dreams.",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Ford provides financial services through <em>Ford</em> <em>Motor</em> Credit Company. Ford employs about 177,000 people worldwide. More information about the company and its products and services is available at corporate.ford.com.\n\nFor news releases, related materials and high-resolution photos and video, visit www.media.ford.com.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Reid\n\n1.313.319.6683\n\[email protected]\n\n\n\nEquity Investment\n\nCommunity\n\nLynn Antipas Tyson\n\n1.914.485.1150\n\[email protected]\n\n\n\nFixed-Income\n\nInvestment\n\nCommunity\n\nJessica Vila-Goulding\n\n1.313.248.3896\n\[email protected]\n\n\n\nShareholder\n\nInquiries\n\n1.800.555.5259 or\n\n1.313.845.8540\n\[email protected]\n\nSource: <em>Ford</em> <em>Motor</em> <em>Company</em>",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ford</em> <em>Motor</em> <em>Company</em> Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "ac54404d-d7d0-4499-b30a-b6b93d2f2fc5",
"title": "Ford Motor Company Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting",
"description": "Ford today published its 2024 proxy statement and announced the date of the company’s 2024 annual meeting of shareholders, which will again be held virtually.\n\n\nThe proxy statement and details...",
"keywords": "Markets",
"snippet": "Ford today published its 2024 proxy statement and announced the date of the company’s 2024 annual meeting of shareholders, which will again be held virtually....",
"url": "https://www.marketscreener.com/quote/stock/FORD-MOTOR-COMPANY-12542/news/Ford-Motor-Company-Issues-2024-Proxy-Statement-Announces-May-9-as-Date-for-Virtual-Annual-Meeting-46319987/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2024-03-29T13:06:05.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "F.SW",
"name": "Ford Motor Company",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 101.675385,
"sentiment_score": 0.428667,
"highlights": [
{
"highlight": "About <em>Ford</em> <em>Motor</em> <em>Company</em>\n\n<em>Ford</em> <em>Motor</em> <em>Company</em> (NYSE: F) is a global company based in Dearborn, Michigan, committed to helping build a better world, where every person is free to move and pursue their dreams.",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Ford provides financial services through <em>Ford</em> <em>Motor</em> Credit Company. Ford employs about 177,000 people worldwide. More information about the company and its products and services is available at corporate.ford.com.\n\nFor news releases, related materials and high-resolution photos and video, visit www.media.ford.com.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ford</em> <em>Motor</em> <em>Company</em> Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "F",
"name": "Ford Motor Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 118.07695,
"sentiment_score": 0.428667,
"highlights": [
{
"highlight": "About <em>Ford</em> <em>Motor</em> <em>Company</em>\n\n<em>Ford</em> <em>Motor</em> <em>Company</em> (<em>NYSE</em>: <em>F</em>) is a global company based in Dearborn, Michigan, committed to helping build a better world, where every person is free to move and pursue their dreams.",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, Ford provides financial services through <em>Ford</em> <em>Motor</em> Credit Company. Ford employs about 177,000 people worldwide. More information about the company and its products and services is available at corporate.ford.com.\n\nFor news releases, related materials and high-resolution photos and video, visit www.media.ford.com.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ford</em> <em>Motor</em> <em>Company</em> Issues 2024 Proxy Statement, Announces May 9 as Date for Virtual Annual Meeting",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "306203ef-a681-4b69-b547-a5e21318ebe2",
"title": "Hercules Capital Stock: Record Year In 2023, 10% Yield (NYSE:HTGC)",
"description": "Hercules Capital had record investment income and NII in 2023 and has closed significant new debt and equity commitments. Read more about HTGC stock here.",
"keywords": "",
"snippet": "8vFanI\n\nBusiness Development Companies, known as BDC's, have been reaping the rewards of rising interest rates since Q2 '22.\n\nHercules Capital, Inc. (NYSE:HTGC)...",
"url": "https://seekingalpha.com/article/4681091-hercules-capital-record-year-in-2023-10-percent-yield",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210130738/image_1210130738.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-29T13:15:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HTGC",
"name": "Hercules Capital, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 107.743225,
"sentiment_score": 0.1102,
"highlights": [
{
"highlight": "<em>Hercules</em> <em>Capital</em>, <em>Inc</em>. (<em>NYSE:HTGC</em>) has seen its core yield rise from 11.1% in Q1 '22 all the way to 14.3% in Q4 '23. 85.9% of HTGC's debt portfolio has floating rates.",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "BDC's offer retail investors high yield exposure to private companies, and some of them, like <em>Hercules</em> <em>Capital</em>, focus on companies which are already backed by venture capital firms. These venture capital firms don't want to lose their investments, and will continue to support these companies. That was crucial during the pandemic.",
"sentiment": 0.6918,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hercules</em> <em>Capital</em> Stock: Record Year In 2023, 10% Yield (<em>NYSE:HTGC</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "HCXY",
"name": "Hercules Capital, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 65.75184,
"sentiment_score": 0.1102,
"highlights": [
{
"highlight": "<em>Hercules</em> <em>Capital</em>, <em>Inc</em>. (NYSE:HTGC) has seen its core yield rise from 11.1% in Q1 '22 all the way to 14.3% in Q4 '23. 85.9% of HTGC's debt portfolio has floating rates.",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "BDC's offer retail investors high yield exposure to private companies, and some of them, like <em>Hercules</em> <em>Capital</em>, focus on companies which are already backed by venture capital firms. These venture capital firms don't want to lose their investments, and will continue to support these companies. That was crucial during the pandemic.",
"sentiment": 0.6918,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hercules</em> <em>Capital</em> Stock: Record Year In 2023, 10% Yield (NYSE:HTGC)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "HCXZ",
"name": "Hercules Capital, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 65.75184,
"sentiment_score": 0.1102,
"highlights": [
{
"highlight": "<em>Hercules</em> <em>Capital</em>, <em>Inc</em>. (NYSE:HTGC) has seen its core yield rise from 11.1% in Q1 '22 all the way to 14.3% in Q4 '23. 85.9% of HTGC's debt portfolio has floating rates.",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "BDC's offer retail investors high yield exposure to private companies, and some of them, like <em>Hercules</em> <em>Capital</em>, focus on companies which are already backed by venture capital firms. These venture capital firms don't want to lose their investments, and will continue to support these companies. That was crucial during the pandemic.",
"sentiment": 0.6918,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hercules</em> <em>Capital</em> Stock: Record Year In 2023, 10% Yield (NYSE:HTGC)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "9e87f7c1-6a4c-4e32-b9f7-765939229ae4",
"title": "神盾以逾5億元價值股票 收購日本老牌 IP 廠6成股權",
"description": "神盾再度展開收購動作,董事會決議以發行新股205萬8150股為對價,取得日本老牌IP公司Curious Holding約...",
"keywords": "",
"snippet": "本文共544字\n\n神盾(6462)再度展開收購動作,董事會決議以發行新股205萬8150股為對價,取得日本老牌IP公司Curious Holding約6...",
"url": "https://money.udn.com/money/story/5612/7865682",
"image_url": "https://pgw.udn.com.tw/gw/photo.php?u=https://uc.udn.com.tw/photo/2024/01/23/2/28805972.jpg&s=Y&x=0&y=192&sw=1281&sh=854&sl=W&fw=1050&exp=3600",
"language": "zh",
"published_at": "2024-03-29T13:13:28.000000Z",
"source": "money.udn.com",
"relevance_score": null,
"entities": [
{
"symbol": "SONY",
"name": "Sony Group Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 12.845393,
"sentiment_score": null,
"highlights": [
{
"highlight": "李宜平表示,Curious Holding成立於2001年,主要提供介面、影像感測器及影像處理矽智財(IP),客戶包含索尼(<em>Sony</em>)、電裝(Denso)及瑞薩(Renesas)等,最先進製程技術達6奈米,年營收約700萬美元,去年營運順利轉盈。\n\n李宜平說,日本政府近年積極扶植半導體產業發展,Curious Holding獲得日本政府補助,神盾希望藉由入主Curious Holding,補強集團IP廣度,並有助於擴展日本市場。\n\n神盾董事會甫於今年1月決議收購先進製程高速傳輸介面及標準元件庫IP廠乾瞻科技100%股權,每1股乾瞻科技換發現金179.48元及0.959341032股神盾普通股,現金對價約26億元,股票對價約21億元,總價金約47億元,股份轉換基準日訂7月1日。",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "0030ec8d-211b-46a2-ad5f-eb25469f73b7",
"title": "神盾擬與Curious進行股份交換,冀完整布局高速傳輸介面IP、拓展日本業務",
"description": "神盾擬與Curious進行股份交換,冀完整布局高速傳輸介面IP、拓展日本業務。 公開資訊觀測站重大訊息公告(6462)神盾-公告本公司召開重大訊息記者會新聞稿內容1.事實發生日:113/03/292.",
"keywords": "",
"snippet": "公開資訊觀測站重大訊息公告\n\n\n\n(6462)神盾-公告本公司召開重大訊息記者會新聞稿內容\n\n\n\n1.事實發生日:113/03/29\n\n2.公司名稱...",
"url": "https://www.moneydj.com/kmdj/news/newsviewer.aspx?a=392d46c1-9cee-4bfd-94ad-fa1d58a6aeae&utm_source=96966657596657961618576896&utm_medium=RSS",
"image_url": "https://www.moneydj.com/infoSvc/thumbnail.aspx?id=392d46c1-9cee-4bfd-94ad-fa1d58a6aeae",
"language": "zh",
"published_at": "2024-03-29T13:04:00.000000Z",
"source": "moneydj.com",
"relevance_score": null,
"entities": [
{
"symbol": "SONY",
"name": "Sony Group Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 8.528495,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:<em>Sony</em> Corporation、Denso Corporation、Renesas Electronics Corporation、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": 0.5423,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PCRFY",
"name": "Panasonic Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 15.126516,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、Renesas Electronics Corporation、<em>Panasonic</em> <em>Corporation</em>、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PCRFF",
"name": "Panasonic Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 15.126516,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、Renesas Electronics Corporation、<em>Panasonic</em> <em>Corporation</em>、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NINOY",
"name": "Nikon Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 16.165949,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、Renesas Electronics Corporation、Panasonic Corporation、<em>Nikon</em> <em>Corporation</em>及FUJIFILM Co.,Ltd.等。",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DNZOY",
"name": "DENSO Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 15.309801,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、<em>Denso</em> <em>Corporation</em>、Renesas Electronics Corporation、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "RNECY",
"name": "Renesas Electronics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 25.296694,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、<em>Renesas</em> <em>Electronics</em> <em>Corporation</em>、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "RNECF",
"name": "Renesas Electronics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 25.294907,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、<em>Renesas</em> <em>Electronics</em> <em>Corporation</em>、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DNZOF",
"name": "DENSO Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 15.309416,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、<em>Denso</em> <em>Corporation</em>、Renesas Electronics Corporation、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "6723.T",
"name": "Renesas Electronics Corporation",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Technology",
"match_score": 25.29431,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、<em>Renesas</em> <em>Electronics</em> <em>Corporation</em>、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "6752.T",
"name": "Panasonic Corporation",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Technology",
"match_score": 9.560379,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、Renesas Electronics Corporation、<em>Panasonic</em> <em>Corporation</em>、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "7731.T",
"name": "Nikon Corporation",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 10.079842,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、Denso Corporation、Renesas Electronics Corporation、Panasonic Corporation、<em>Nikon</em> <em>Corporation</em>及FUJIFILM Co.,Ltd.等。",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "6902.T",
"name": "DENSO Corporation",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 15.309379,
"sentiment_score": null,
"highlights": [
{
"highlight": "Curious是專注於開發和設計類比及混合IC之無晶圓廠設計公司,主要提供用於積體電路、大型積體電路之傳輸介面及相關IP授權,包括:索尼半導體解決方案SLVS-EC、相機PHY介面IP(包括SER/DES)、平面顯示器(LCD/Plasma)介面IP、影像感測器IP、影像處理IP、ASIP/ASIC(客製化IP/IC),主要業務及合作公司多為日本知名大型企業,例如:Sony Corporation、<em>Denso</em> <em>Corporation</em>、Renesas Electronics Corporation、Panasonic Corporation、Nikon Corporation及FUJIFILM Co.,Ltd.等。",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "ce64dcc3-b65b-4a3e-a775-c8107192b7a2",
"title": "American Battery Technology Company Appoints Financial Industry Veteran, Susan Yun Lee, to Board of Directors By Investing.com",
"description": "American Battery Technology Company Appoints Financial Industry Veteran, Susan Yun Lee, to Board of Directors",
"keywords": "",
"snippet": "RENO, Nev. , March 29, 2024 /PRNewswire/ -- American Battery Technology Company ( ) (NASDAQ: ABAT), an integrated critical battery materials company that is com...",
"url": "https://www.investing.com/news/press-releases/american-battery-technology-company-appoints-financial-industry-veteran-susan-yun-lee-to-board-of-directors-93CH-3358037",
"image_url": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
"language": "en",
"published_at": "2024-03-29T13:12:08.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "DIS",
"name": "The Walt Disney Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 31.844736,
"sentiment_score": 0,
"highlights": [
{
"highlight": "She began her career with strategy roles with Bain & Co. and <em>The</em> <em>Walt</em> <em>Disney</em> <em>Company</em> (NYSE: ) and has also worked as a partner at Angeles Investment Advisors, an investment advisory firm for institutional investors, where she steered the firm's private equity division and managed its portfolio.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "e8566092-388e-45aa-9cf7-a90bc8048c0f",
"title": "Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update By Investing.com",
"description": "Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update",
"keywords": "",
"snippet": "- Data for masked anti-CTLA-4 SAFEbody ® ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsat...",
"url": "https://www.investing.com/news/press-releases/adagene-reports-full-year-2023-financial-results-and-provides-corporate-update-93CH-3358040",
"image_url": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
"language": "en",
"published_at": "2024-03-29T13:12:07.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 8.838233,
"sentiment_score": 0.07655,
"highlights": [
{
"highlight": "This enables the company to broaden its dose expansion cohorts for MSS CRC at selected dosing regimens, and potentially in other tumor types, in its clinical trial collaboration and supply agreement with <em>Merck</em>.",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "KEYTRUDA ® is a registered trademark of <em>Merck</em> Sharp (OTC: ) & Dohme LLC, a subsidiary of <em>Merck</em> & <em>Co</em>., <em>Inc</em>., Rahway, NJ, USA.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "49021a38-3e90-4604-8d86-bb69b18f65ba",
"title": "Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update By Investing.com",
"description": "Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update",
"keywords": "",
"snippet": "AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates (NASDAQ: ), Inc. (Nasdaq: MTEM, Molecular Templates, or MTEM), a clinical-stage biopharmac...",
"url": "https://www.investing.com/news/press-releases/molecular-templates-inc-reports-fourth-quarter-2023-financial-results-and-business-update-93CH-3358018",
"image_url": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
"language": "en",
"published_at": "2024-03-29T12:32:08.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "MTEM",
"name": "Molecular Templates, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 141.50284,
"sentiment_score": 0.1428,
"highlights": [
{
"highlight": "AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- <em>Molecular</em> <em>Templates</em> (NASDAQ: ), Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>MTEM</em>, <em>Molecular</em> <em>Templates</em>, or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), to create novel therapies with potent differentiated mechanisms of action for cancer, today reported financial results for the fourth quarter",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Molecular</em> <em>Templates</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Templates</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Molecular</em> <em>Templates</em>\n\n<em>Molecular</em> <em>Templates</em> is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Molecular</em> <em>Templates</em> disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act's Safe Harbor for forward-looking statements.",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "In addition, when or if used in this press release, the words may, could, should, continue, anticipate, potential, believe, estimate, appears, expect, intend, plan, predict and similar expressions and their variants, as they relate to <em>Molecular</em> <em>Templates</em> may identify forward-looking statements.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors including, but not limited to the following: the continued availability of financing on commercially reasonable terms, whether <em>Molecular</em> <em>Templates</em>' cash resources will be sufficient to fund its continuing operations; the",
"sentiment": 0.1016,
"highlighted_in": "main_text"
},
{
"highlight": "results of MTEM's ongoing clinical studies and the ability to effectively operate MTEM, and those risks identified under the heading Risk Factors in <em>Molecular</em> <em>Templates</em>' filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the year ended December 31, 2023 and any subsequent reports filed with the SEC.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Any forward-looking statements contained in this press release speak only as of the date hereof, and <em>Molecular</em> <em>Templates</em> specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise.\n\nContacts:[email protected]\n\nSource: <em>Molecular</em> <em>Templates</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Molecular</em> <em>Templates</em>, <em>Inc</em>. Reports Fourth Quarter 2023 Financial Results and Business Update By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BMY",
"name": "Bristol-Myers Squibb Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 21.818874,
"sentiment_score": 0.47965,
"highlights": [
{
"highlight": "Key Milestones for 2024\n\nClinical data on MT-6402 expansion cohorts in low and high PD-L1+ HNSCC patients\n\nClinical data from dose escalation study for MT-8421 Treg depleting agent in solid tumors\n\n<em>Bristol</em>-<em>Myers</em> <em>Squibb</em> (NYSE: ) Collaboration Agreement\n\nOn March 13, 2024, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> notified the Company that following a corporate portfolio",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Revenues for the fourth quarter of 2023 were comprised of revenues from collaborative research and development agreements with <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> and grant revenue.\n\nTotal research and development expenses for the fourth quarter of 2023 were $8.8 million, compared with $17.6 million for the same period in 2022.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "99443962-c32b-4ae4-b592-afbd411250c2",
"title": "KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update By Investing.com",
"description": "KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update",
"keywords": "",
"snippet": "-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by year-end 2024 --\n\n-- Exploring opportunities to expand KPI-012 into addi...",
"url": "https://www.investing.com/news/press-releases/kala-bio-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-corporate-update-93CH-3358011",
"image_url": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
"language": "en",
"published_at": "2024-03-29T12:12:08.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.989532,
"sentiment_score": 0.17112,
"highlights": [
{
"highlight": "The decrease was primarily due to the sale of KALA's commercial portfolio to <em>Alcon</em> (NYSE: ) Inc. (<em>Alcon</em>) in July 2022.\n\nFor the quarter ended December 31, 2023, selling, general and administrative (SG&A) expenses were $4.6 million, compared to $5.8 million for the same period in 2022.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The decrease was primarily due to the sale of KALA's commercial portfolio to <em>Alcon</em> (NYSE: ) Inc. (<em>Alcon</em>) in July 2022. R&D Expenses: For the quarter ended December 31, 2023, research and development (R&D) expenses were $4.7 million, compared to $3.3 million for the same period in 2022.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Results for the Full Year Ended December 31, 2023:\n\nNet Product Revenues: KALA did not recognize product revenues in the full year ended December 31, 2023 as a result of the sale of its commercial portfolio to <em>Alcon</em> in July 2022. For the full year ended December 31, 2022, Kala reported net product revenues of $3.9 million.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "KALA did not recognize product revenues in the full year ended December 31, 2023 as a result of the sale of its commercial portfolio to <em>Alcon</em> in July 2022. For the full year ended December 31, 2022, Kala reported net product revenues of $3.9 million.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Cost of Product Revenues: KALA did not record cost of product revenues in the full year ended December 31, 2023 as a result of the sale of its commercial portfolio to <em>Alcon</em> in July 2022. For the full year ended December 31, 2022, cost of product revenues was $2.6 million.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "KALA did not record cost of product revenues in the full year ended December 31, 2023 as a result of the sale of its commercial portfolio to <em>Alcon</em> in July 2022. For the full year ended December 31, 2022, cost of product revenues was $2.6 million.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The decrease was primarily due to the sale of KALA's commercial portfolio to <em>Alcon</em>.\n\nFor the full year ended December 31, 2023, SG&A expenses were $20.6 million, compared to $65.0 million for the same period in 2022. The decrease was primarily due to the sale of KALA's commercial portfolio to <em>Alcon</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "full year ended December 31, 2023, KALA did not report a loss on extinguishment of debt, compared to a loss of $2.6 million in the same period in 2022 as a result of a partial prepayment of outstanding principal and related fees under its loan agreement with Oxford Finance LLC in connection with the closing of the sale of its commercial business to <em>Alcon</em>",
"sentiment": 0.5832,
"highlighted_in": "main_text"
},
{
"highlight": "Gain on Sale of Commercial Business: For the full year ended December 31, 2023, KALA did not report a gain on sale of commercial business, compared to a gain of $47.0 million for the same period in 2022 related to the sale of its commercial business to <em>Alcon</em>.",
"sentiment": 0.7267,
"highlighted_in": "main_text"
},
{
"highlight": "For the full year ended December 31, 2023, KALA did not report a gain on sale of commercial business, compared to a gain of $47.0 million for the same period in 2022 related to the sale of its commercial business to <em>Alcon</em>.",
"sentiment": 0.4013,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "c9c8268c-7312-4b32-b89f-b4e685779a75",
"title": "Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 By Investing.com",
"description": "Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023",
"keywords": "",
"snippet": "Viactiv ® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared...",
"url": "https://www.investing.com/news/press-releases/guardion-health-sciences-announces-financial-results-for-the-year-ended-december-31-2023-93CH-3357984",
"image_url": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
"language": "en",
"published_at": "2024-03-29T10:28:07.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "BEST",
"name": "BEST Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 6.961092,
"sentiment_score": 0.305325,
"highlights": [
{
"highlight": "Recent Developments in 2024\n\nAgreement to Sell Activ Nutritional, LLC\n\nOn January 30, 2024, the Company entered into an Equity Purchase Agreement (the Purchase Agreement) with Doctor's <em>Best</em> <em>Inc</em>., a Delaware corporation, for the sale of all of the outstanding equity interests of Activ Nutritional, LLC (Activ) for aggregate cash consideration of $17.2",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "Doctor's <em>Best</em> <em>Inc</em>. is a wholly-owned subsidiary of Kingdomway USA Corp., the U.S. subsidiary holding company of Xiamen Kingdomway Group Company (XKDW), which is publicly listed on the Shenzhen Stock Exchange.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "uncertainties, risks and changes in circumstances that are difficult to predict, and involve unknown risks and uncertainties that may individually or materially impact the matters discussed herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the successful completion of the sale of Activ to Doctor's <em>Best</em>",
"sentiment": 0.339,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Inc</em>., the use of the proceeds received from the sale, the Company's ability to continue to fund its operations, including its ocular healthcare business, subsequent to the sale, any replacement and integration of new management team members, the implementation of new financial, management, accounting and business software systems, supply chain disruptions",
"sentiment": -0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GHSI",
"name": "Guardion Health Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 121.78165,
"sentiment_score": 0.2665,
"highlights": [
{
"highlight": "Viactiv ® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022\n\nHOUSTON, TEXAS, March 29, 2024 (GLOBE NEWSWIRE) -- <em>Guardion</em> <em>Health</em> <em>Sciences</em>, <em>Inc</em>.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>GHSI</em>) (Guardion or the Company), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for the year ended December 31, 2023.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Guardion</em> <em>Health</em> <em>Sciences</em>, <em>Inc</em>.\n\n<em>Guardion</em> <em>Health</em> <em>Sciences</em>, <em>Inc</em>. (<em>Nasdaq</em>: <em>GHSI</em>) is a clinical nutrition company that offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about <em>Guardion</em> <em>Health</em> <em>Sciences</em>, <em>Inc</em>.,¯Contact:\n\[email protected]\n\n\n\nPhone: 1-800 873-5141 Ext 208",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Guardion</em> <em>Health</em> <em>Sciences</em> Announces Financial Results for the Year Ended December 31, 2023 By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "002626.SZ",
"name": "Xiamen Kingdomway Group Company",
"exchange": null,
"exchange_long": null,
"country": "cz",
"type": "equity",
"industry": "Healthcare",
"match_score": 23.715092,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., the U.S. subsidiary holding company of <em>Xiamen</em> <em>Kingdomway</em> <em>Group</em> <em>Company</em> (XKDW), which is publicly listed on the Shenzhen Stock Exchange.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "a40c2d94-f55e-422d-af7e-0200dcc27956",
"title": "Sunnova (NOVA) Faces Lawsuit After Congressional Probe of “Troubling Sales Practices”– Hagens Berman",
"description": "HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages NOVA Investors Who Suffered Substantial Losses to Contact its Attorneys...",
"keywords": "Hagens Berman Sobol Shapiro LLP, NOVA class action, NOVA investor, NOVA investor fraud, NOVA lawsuit, NOVA securities class action, NOVA securities fraud, NOVA stock, Class Action",
"snippet": "SAN FRANCISCO, March 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Sunnova Energy International Inc. (NYSE: NOVA) investors who suffered substantial losses t...",
"url": "https://www.globenewswire.com/news-release/2024/03/29/2854738/32716/en/Sunnova-NOVA-Faces-Lawsuit-After-Congressional-Probe-of-Troubling-Sales-Practices-Hagens-Berman.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/51670c91-d369-4a8c-8102-d393de9f6d19",
"language": "en",
"published_at": "2024-03-29T13:07:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "NOVA",
"name": "Sunnova Energy International Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 66.37481,
"sentiment_score": -0.38915,
"highlights": [
{
"highlight": "SAN FRANCISCO, March 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges <em>Sunnova</em> <em>Energy</em> <em>International</em> <em>Inc</em>. (<em>NYSE</em>: <em>NOVA</em>) investors who suffered substantial losses to submit your losses now.",
"sentiment": -0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "Class Period: Feb. 25, 2020 – Dec. 7, 2023\n\nLead Plaintiff Deadline: Apr. 16, 2024\n\nVisit: www.hbsslaw.com/investor-fraud/NOVA Contact An Attorney Now: [email protected] 844-916-0895\n\n<em>Sunnova</em> <em>Energy</em> <em>International</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b8b9d55f-0735-44d4-8e30-3b1e043f0f8c",
"title": "3 Market-Beating Stocks to Buy in April",
"description": "Stocks Analysis by Investing.com (Jesse Cohen) covering: Nasdaq 100, S&P 500, Dow Jones Industrial Average, Chevron Corp. Read Investing.com (Jesse Cohen)'s latest article on Investing.com",
"keywords": "",
"snippet": "The S&P 500 closed out a blowout month and quarter at a new record high to notch its best start to a year since 2019.\n\nIdentifying promising opportunities becom...",
"url": "https://www.investing.com/analysis/3-marketbeating-stocks-to-buy-in-april-200647220",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investingcom_analysis_og.jpg",
"language": "en",
"published_at": "2024-03-29T13:07:00.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVX",
"name": "Chevron Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 12.094408,
"sentiment_score": 0.875,
"highlights": [
{
"highlight": "Shares have increased 16.3% since the start of 2024, blowing past the gains made by competitors <em>Chevron</em> (NYSE: ) (+5.7%), Shell (LON: ) (+1.9%), and BP (NYSE: ) (+6.4%) over the same timeframe.\n\nSource: InvestingPro\n\nIt is worth noting that the quantitative models in InvestingPro point to a gain of 6.7% in XOM stock from Thursday’s closing price.",
"sentiment": 0.875,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PGRE",
"name": "Paramount Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 11.458766,
"sentiment_score": 0.802,
"highlights": [
{
"highlight": "Identifying promising opportunities becomes <em>paramount</em> amid the current backdrop.\n\nUsing the InvestingPro Stock Screener, I searched for market-beating stocks that offer investors the potential for attractive returns in April.",
"sentiment": 0.802,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NYSE",
"total_documents": 1222,
"sentiment_avg": 0.2843085631113861
}
]
}
Other details
Country
- us
- 4,171